載入...
Pazopanib in the treatment of advanced renal cell carcinoma
Pazopanib is an orally available multitargeted tyrosine kinase inhibitor (a class of targeted therapies) that inhibits tumor angiogenesis and cell proliferation. The safety and efficacy of pazopanib (noninferior to sunitinib for progression-free survival) in patients with advanced or metastatic rena...
Na minha lista:
| 發表在: | Ther Adv Urol |
|---|---|
| Main Authors: | , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
SAGE Publications
2016
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4707425/ https://ncbi.nlm.nih.gov/pubmed/26834841 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756287215614236 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|